Because of fluctuating rebate levels, types and opportunities, many healthcare providers have limited oversight into their overall rebate capture opportunity. An estimated 25% of a drug’s wholesale acquisition cost will be comprised of manufacturer rebates, most of which will go unclaimed.
This program is different than discount programs. It is based on a data analytics platform which has partnered with leading benefit managers, and stays constantly up to date with the latest rebates.
Founded 5 years ago, 3Rx Holdings prides itself on bringing to the medical community the “Best in Class” Advance Testing Protocols available in the Genetics and Molecular Space, as well as exciting Ancillary Services to Create Profit Centers in the Medical Community Marketplace.
They specialize in Pharmacy Remuneration Models, “NO COST” opportunities for Independent Pharmacies, Infusion Centers, Hematology/Oncology, HIV centers and Specialty Pharmacies.
Contact 3Rx Holdings for more Information >>
Become a PCA Bronze Member for FREE today.